BRCA1 and ovarian cancer: Following the identification of two predisposition genes (BRCA1 and BRCA2) that increase the risk of breast and/or ovarian cancer (Miki et al, 1994; Wooster et al, 1995), there has been a gradual introduction of genetic testing into the clinical context.